Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Intracranial Aneurysm Market, by End-use
1.4.2 LAMEA Intracranial Aneurysm Market, by Type
1.4.3 LAMEA Intracranial Aneurysm Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. LAMEA Intracranial Aneurysm Market by End-use
4.1 LAMEA Hospitals Market by Country
4.2 LAMEA Clinics Market by Country
4.3 LAMEA Others Market by Country
Chapter 5. LAMEA Intracranial Aneurysm Market by Type
5.1 LAMEA Endovascular Coiling Market by Country
5.2 LAMEA Flow Diverters Market by Country
5.3 LAMEA Surgical Clipping Market by Country
5.4 LAMEA Others Market by Country
Chapter 6. LAMEA Intracranial Aneurysm Market by Country
6.1 Brazil Intracranial Aneurysm Market
6.1.1 Brazil Intracranial Aneurysm Market by End-use
6.1.2 Brazil Intracranial Aneurysm Market by Type
6.2 Argentina Intracranial Aneurysm Market
6.2.1 Argentina Intracranial Aneurysm Market by End-use
6.2.2 Argentina Intracranial Aneurysm Market by Type
6.3 UAE Intracranial Aneurysm Market
6.3.1 UAE Intracranial Aneurysm Market by End-use
6.3.2 UAE Intracranial Aneurysm Market by Type
6.4 Saudi Arabia Intracranial Aneurysm Market
6.4.1 Saudi Arabia Intracranial Aneurysm Market by End-use
6.4.2 Saudi Arabia Intracranial Aneurysm Market by Type
6.5 South Africa Intracranial Aneurysm Market
6.5.1 South Africa Intracranial Aneurysm Market by End-use
6.5.2 South Africa Intracranial Aneurysm Market by Type
6.6 Nigeria Intracranial Aneurysm Market
6.6.1 Nigeria Intracranial Aneurysm Market by End-use
6.6.2 Nigeria Intracranial Aneurysm Market by Type
6.7 Rest of LAMEA Intracranial Aneurysm Market
6.7.1 Rest of LAMEA Intracranial Aneurysm Market by End-use
6.7.2 Rest of LAMEA Intracranial Aneurysm Market by Type
Chapter 7. Company Profiles
7.1 MicroVention, Inc. (Terumo Corporation)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Trials and Approvals:
7.2 Medtronic PLC
7.2.1 Company overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Product Launches and Product Expansions:
7.2.6 SWOT Analysis
7.3 Stryker Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.3.5.2 Acquisition and Mergers:
7.3.6 SWOT Analysis
7.4 MicroPort Scientific Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 SWOT Analysis
7.5 Johnson & Johnson
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental & Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.5.2 Product Launches and Product Expansions:
7.5.6 SWOT Analysis
7.6 B. Braun Melsungen AG
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 SWOT Analysis
7.7 Integra LifeSciences Holdings Corporation
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 SWOT Analysis
7.8 Delta Surgical
7.8.1 Company Overview
7.9 Penumbra, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses
Unique Offerings 